Navigation Links
MetaChip provides quick, efficient toxicity screening of potential drugs

laboratory and animal testing. It is believed to act by inhibiting the entry of HIV and other pathogens into body cells. BufferGel, a product of ReProtect, Inc., Baltimore, MD, boosts the natural acidity of the vagina in the presence of seminal fluid that neutralizes the vaginal environment. An acidic environment inactivates HIV as well as other pathogens.

Each woman in the trial will be placed at random into one of four equally sized groups. One group will use BufferGel before each act of sexual intercourse, one group will use PRO 2000, one group will use a placebo gel, and the final group will not use any gel. In addition, all participants will receive condoms and extensive prevention counseling at each clinic visit.

The trial is one of numerous studies conducted through NIH's HIV Prevention Trials Network (HPTN), which is funded by NIAID, the National Institute of Child Health and Human Development, the National Institute on Drug Abuse and the National Institute of Mental Health. More information about this study (HPTN 035) is available at www.hptn.org/index.htm. The protocol chair of the study is Salim Abdool Karim, MBChB, Ph.D., of the University of KwaZulu-Natal in Durban, South Africa.


'"/>

Source:


Page: 1 2

Related biology news :

1. NYU and MSKCC research provides model for understanding chemically induced cancer initiation
2. Nature provides inspiration for important new adhesive
3. New plant DNA libraries provides massive boost to worlds plant researchers
4. NASA satellite data provides rapid analysis of Amazon deforestation
5. Study provides insight into cellular defenses against genetic mutation
6. Customized gene chip provides rapid detection of genetic changes in childrens cancer
7. Vaccine provides 100 percent protection against avian flu virus in animal study
8. New hybrid virus provides targeted molecular imaging of cancer
9. Ancient DNA provides clues to the evolution of social behavior
10. Brittlestar provides new model for stem cell research
11. Use of amino acid supplement following a heart attack provides no benefit, may be harmful
Post Your Comments:
(Date:12/11/2009)... children understand that green plants photosynthesize, absorb carbon ... profound global-scale effects that photosynthesis has had on ... the origins and evolution of photosynthesis is Jeffrey ... of Life Sciences. , Oxygen, one of the ... and their descendants (including algae and higher plants), ...
(Date:12/11/2009)... nearly two decades, Ivy Pike, an associate professor of ... ethnic groups in rural northern Kenya to understand how ... living there. , The results of her and her ... in three pastoralist communities of northern Kenya: A conceptual ... Social Science and Medicine , in collaboration with ...
(Date:12/11/2009)... December 11, 2009 Keystone Symposia on ... the appointment of five new Keystone Symposia Fellows ... enables five talented early-career life scientists (postdoctoral trainees ... program development process for one year. Fellows are ... as a commitment to promoting diversity in the ...
Breaking Biology News(10 mins):'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3UA-led study grapples with health effects of low-intensity warfare 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 3Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 4Reportlinker Adds World Botulinum Toxin Market Report 56773 1Reportlinker Adds World Botulinum Toxin Market Report 56773 2Reportlinker Adds World Botulinum Toxin Market Report 56773 3Reportlinker Adds World Botulinum Toxin Market Report 56773 4Reportlinker Adds World Botulinum Toxin Market Report 56773 5Reportlinker Adds World Botulinum Toxin Market Report 56773 6Reportlinker Adds World Botulinum Toxin Market Report 56773 7Reportlinker Adds World Botulinum Toxin Market Report 56773 8Reportlinker Adds World Botulinum Toxin Market Report 56773 9Reportlinker Adds World Botulinum Toxin Market Report 56773 10Reportlinker Adds World Botulinum Toxin Market Report 56773 11Reportlinker Adds World Botulinum Toxin Market Report 56773 12Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 1Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 2Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 3Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 4Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 5Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 6Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 7Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 8Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 9Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 10Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 11Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 12Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 13Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 14Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 15Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 16Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 17Reportlinker Adds US and European Radiopharmaceuticals Market Report 56769 18Groups are key to good health 56765 1Groups are key to good health 56765 2Groups are key to good health 56765 3
... with lead partner Women & Infants Hospital of Rhode ... expand its participation in the National Children,s Study, a ... The National Institute of Child Health and Human Development ... the National Institutes of Health, announced the award today. ...
... A UC Riverside-led team of biomedical scientists has found ... treat acne and skin infections, can be used to treat ... of mental impairment and the most common cause of autism. ... the approval of a new clinical trial in Toronto, Canada, ...
... his State of the Union Address on January 23, 2007, ... oil imports, "We must increase the supply of alternative fuels, ... gallons of renewable and alternative fuels in 2017." , ... in the 2008 Farm Bill and a $45 subsidy per ...
Other Biology News:Brown University and Women & Infants Hospital expand national children's study to Bristol County 2Brown University and Women & Infants Hospital expand national children's study to Bristol County 3Brown University and Women & Infants Hospital expand national children's study to Bristol County 4UCR researchers propose minocycline as a promising drug for patients with Fragile X syndrome 2UCR researchers propose minocycline as a promising drug for patients with Fragile X syndrome 3Mandate for biofuels production requires science-based policy and global perspective 2
(Date:12/14/2009)... Boston Scientific Corporation (NYSE: BSX ... of $2 billion aggregate principal amount of its senior ... public offering consists of $850 million of 4.50 percent ... notes due January 2020 and $300 million of 7.375 ... to use the net proceeds for general corporate purposes, ...
(Date:12/14/2009)... of Brookfield Engineering’s Powder Flow Tester – helping Brookfield move ... footprint and more compact design. , ... ... US-based thermoforming company, has completed the delivery of Brookfield Engineering’s ... to a plastic enclosure with a smaller footprint and more ...
(Date:12/11/2009)... 2009 miRagen Therapeutics, Inc., a biopharmaceutical company ... microRNA-based therapeutics for cardiovascular and muscle disease, today ... (miR-206) plays a crucial role in the progression ... disease) and in neuromuscular synaptic regeneration in mice. ... issue of the journal Science , reveal ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
Breaking Biology Technology:Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... its revolutionary Trusted LASIK Eye Surgeons directory service ... . What sets the Trusted LASIK Surgeons directory ... only the best LASIK Surgeons in the United ... LASIK Surgeon Dr. R. Wayne Bowman, are screened ...
... Therapeutics, Inc., a,biotechnology company focused on the ... poorly controlled inflammation, announced today,the successful completion ... and pharmacokinetics study of LT-NS001, the Company,s ... from December, 2007,through July, 2008 in normal ...
... LifeVantage Corporation,(OTC Bulletin Board: LFVN), the maker of Protandim(R), ... of aging, today announced,that the company,s President & CEO, ... 3-Minute Press Show., The interview gives viewers an ... latest press release., To view ...
Other Biology Technology:Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory 2Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory 3Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory 4Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory 5Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory 6Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug 2[video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.net's 3-Minute Press Show 2
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
Mouse monoclonal [3A7.A11] to Thymidylate Synthase ( Abpromise for all tested applications). entrezGeneID: 7298 SwissProtID: P04818...
PKA Sampler Kit 10 mu g each...
DNA Repair Sampler Kit 10g each...
Biology Products: